T-box transcription factor 2 (TBX2)

T-box transcription factor 2 (TBX2) is a DNA-binding transcriptional repressor in the T-box family, characterized by a conserved T-box domain. TBX2 plays fundamental roles in embryonic and fetal development, controlling gene expression programs for organogenesis, limb, heart, and brain formation, and regulation of cell fate and proliferation[1][2][3][4]. Unlike most T-box proteins, TBX2 acts predominantly as a transcriptional repressor, directly inhibiting cell cycle regulators such as p21Cip1 and p14ARF, thereby suppressing cellular senescence. TBX2 is tightly regulated in normal tissues, but frequently overexpressed in a wide range of cancers, where it promotes oncogenic processes including cell proliferation, evasion of apoptosis, epithelial-to-mesenchymal transition, invasiveness, and therapeutic resistance[2][4]. Its dysregulation is implicated in diverse congenital malformations (cardiac, skeletal, and limb defects) and several cancer forms, making it both a biomarker and a therapeutic target. However, no approved drugs directly target TBX2 in current practice[1][2][4].

Other names

TBX2T-box 2T-box transcription factor 2Tbx2

Transcriptional repression of tumor suppressor genes (such as p21Cip1, p14ARF, PTEN, NDRG1, CST6, E-cadherin) Recruitment of chromatin-modifying enzymes (e.g., histone deacetylases) Complex formation with co-repressors (e.g., Rb1, EGR1, HP1/KAP1)[2][4][6]